Status:

RECRUITING

Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an

Lead Sponsor:

Xi'an No.3 Hospital

Conditions:

Acute Ischemic Stroke

Thrombolysis

Eligibility:

All Genders

18-100 years

Brief Summary

Objective: To observe the practical application of the standardized green channel treatment system for stroke in Xi 'an in the real world. Methods: Clinical data and information of patients with acute...

Detailed Description

The standardized green channel treatment system for acute ischemic stroke includes: Triage nurse triage timely, rapid assessment emergency doctor, suspected stroke the green channel, immediately start...

Eligibility Criteria

Inclusion

  • 18 years old;
  • Consistent with the diagnosis of acute ischemic stroke;
  • 24 hours from onset to enrollment;
  • Informed consent

Exclusion

  • Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis);
  • Stroke patients caused by brain tumor, brain trauma and blood diseases;
  • Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke;
  • Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination;
  • Patients with severe hepatic and renal insufficiency (Note: Hepatic insufficiency refers to ALT or AST values greater than 2 times the upper normal limit; Renal insufficiency refers to blood creatinine value greater than 2 times the normal upper limit);
  • Suffering from other serious life-threatening diseases with an expected survival time of less than 3 months;
  • Other diseases that limit neurological function evaluation or affect patient follow-up;
  • A woman planning to be pregnant or breastfeeding;
  • Currently participating in other clinical trials;
  • Refuse to participate in the registration of investigators

Key Trial Info

Start Date :

June 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 31 2028

Estimated Enrollment :

3600 Patients enrolled

Trial Details

Trial ID

NCT05424978

Start Date

June 1 2022

End Date

July 31 2028

Last Update

January 26 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xi 'an No.3 Hospital

Xi'an, Shaanxi, China, 710018